InnovaDerma PLC Publication of Prospectus (2104V)
April 12 2021 - 12:19PM
UK Regulatory
TIDMIDP
RNS Number : 2104V
InnovaDerma PLC
12 April 2021
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR
INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF
AMERICA (SUBJECT TO CERTAIN LIMITED EXCEPTIONS), AUSTRALIA, NEW
ZEALAND, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER
JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE
IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO.
596/2014) AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE
OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").
TERMS NOT OTHERWISE DEFINED HEREIN SHALL HAVE THE MEANINGS GIVEN
TO THEM IN THE COMPANY'S ANNOUNCEMENT RELEASED AT 09:19 A.M. 20
JANUARY 2021.
12 April 2021
InnovaDerma PLC
("InnovaDerma" or the "Company")
Publication of Prospectus
Further to the announcement today relating to the proposed
Fundraising, the Company is pleased to announced the prospectus and
circular (the "Prospectus") has been approved by the Financial
Conduct Authority and will be published today.
The Prospectus will shortly be posted to Shareholders.
The Prospectus also includes a notice of a general meeting of
the Company, to be held in connection with the Fundraising at 10:00
a.m. on 29 April 2021. Shareholders are reminded to review
carefully the actions to be taken by them in connection with the
General Meeting, which are detailed in the Prospectus.
A copy of the Prospectus will be submitted to the National
Storage Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism . The
Prospectus is also available for inspection at the Company's
registered office at 27 Old Gloucester Street
London WC1N 3AX and is available on the Company's website:
https://www.innovaderma.com/investor-relations/ .
Further enquiries
InnovaDerma
Blake Hughes c/o TB Cardew
finnCap Group
Geoff Nash/Kate Bannatyne/Edward Whiley +44 (0)207 220 0500
Alice Lane/Charlotte Sutcliffe - Corporate Broking www.finncap.com
----------------------------
TB Cardew
Shan Shan Willenbrock/ + 44 (0)7775 848537
Olivia Rosser + 44 (0)20 7930 0777
innovaDerma@tbcardew.com
----------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PDIITMRTMTBBBJB
(END) Dow Jones Newswires
April 12, 2021 13:19 ET (17:19 GMT)
Innovaderma (LSE:IDP)
Historical Stock Chart
From Feb 2024 to Mar 2024
Innovaderma (LSE:IDP)
Historical Stock Chart
From Mar 2023 to Mar 2024